register

News & Trends - MedTech & Diagnostics

Stryker closes $500m Mobius Imaging and Cardan Robotics acquisition

Health Industry Hub | October 23, 2019 |

Stryker announced its acquisition of Mobius Imaging, a leader in point-of-care imaging technology, and its sister company, Cardan Robotics.

Stryker was the first orthopedics major to bet large on robotics with the $1.68 billion acquisition of Mako Surgical in December 2013. Last month Stryker agreed to pay $370 million up front, with another $130 million on the line in milestones, for Mobius and sister company GYS Tech, which operates under the Cardan Robotics brand.

Mobius developed the Airo TruCT scanner, which won 510(k) clearance from the FDA in April 2018. Founded in 2015, Cardan is developing robotics and navigation technologies for spinal procedures.

“Mobius Imaging and Cardan Robotics bring expertise in advanced imaging and robotics, as well as a robust product pipeline, that will provide Stryker the opportunity to increase its presence in Orthopaedics, Spine and Neurotechnology,” said Spencer Stiles, Stryker’s Group President, Orthopaedics and Spine. “With this acquisition, we are positioned to make healthcare better by providing more complete procedural solutions, including sales, service, and support.  We remain committed to our surgeons and helping them achieve the best possible outcomes for their patients.”

You may also like Competitive grants to turn MedTech discoveries into clinical reality


News & Trends - Pharmaceuticals

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Government inaction on mental illness faces overwhelming criticism ahead of federal election

Health Industry Hub | October 11, 2024 |

Pharma News: The Federal Government must strengthen its support for individuals with severe and complex mental illness to prevent future […]

More


News & Trends - Pharmaceuticals

New CVD model marks a critical step in the right direction

New CVD model marks a critical step in the right direction

Health Industry Hub | October 11, 2024 |

Pharma News: Cardiovascular disease (CVD) affects four million Australians and claims one life every 12 minutes. A recent heart screening […]

More


News & Trends - Pharmaceuticals

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Alzheimer’s disease set to cost $17 billion: Lilly urges government to keep pace with innovation

Health Industry Hub | October 11, 2024 |

Pharma News: A newly commissioned report by Lilly, unveiled at Parliament House, has shed light on the health, societal, and […]

More


Leadership & Management

J&J MedTech appoints new ANZ leader

J&J MedTech appoints new ANZ leader

Health Industry Hub | October 10, 2024 |

Leadership & Management: Johnson & Johnson has been appointed a new Managing Director for its medtech business in Australia and […]

More


This content is copyright protected. Please subscribe to gain access.